论文信息 - SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants - 字舞流文

SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants

L. Zhong | R. Zheng | Z. Cao | Y. Xu | S. Ma | S. Yang | Y-Q Wei | H. Xie | J.J. Liu | J. Yang | L-J Wang | C-H Zhang | B-L Wang | Z-R Wang